Showing results (91-100 of 283) with videos related to
Sort By:
Pageof 29
Journal of Gastroenterology and Hepatology|April 10, 2008
Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapySoocheol Jeong, Yoshiiku Kawakami, Mikiya Kitamoto, et al.Journal of Hepatology|October 27, 2009
Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric miceNobuhiko Hiraga, Michio Imamura, Tsuyoshi Hatakeyama, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 19, 2016
Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acidYohji Honda, Hiroshi Aikata, Fumi Honda, et al.Journal of Gastroenterology|September 6, 2019
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosisMaiko Namba, Akira Hiramatsu, Hiroshi Aikata, et al.The Journal of Infectious Diseases|May 13, 2009
G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infectionChiemi Noguchi, Michio Imamura, Masataka Tsuge, et al.Virus Research|November 17, 2015
Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric miceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.European Journal of Gastroenterology & Hepatology|July 3, 2023
Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetesYutaro Ogawa, Takashi Nakahara, Yuwa Ando, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 31, 2016
IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis CNami Mori, Michio Imamura, Yoshiiku Kawakami, et al.Plos One|October 24, 2012
Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycleC Nelson Hayes, Sakura Akamatsu, Masataka Tsuge, et al.Plos Computational Biology|August 3, 2023
Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kineticsAtesmachew Hailegiorgis, Yuji Ishida, Nicholson Collier, et al.Pageof 29